Previous Article | Next Article 
Infection and Immunity, November 2002, p. 5982-5989, Vol. 70, No. 11
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.11.5982-5989.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Specific Immune Responses and Enhancement of Murine Pulmonary Clearance of Moraxella catarrhalis by Intranasal Immunization with a Detoxified Lipooligosaccharide Conjugate Vaccine
Xinan Jiao, Takashi Hirano, Yingchun Hou, and Xin-Xing Gu*
National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Rockville, Maryland 20850
Received 29 April 2002/
Returned for modification 5 June 2002/
Accepted 5 August 2002
Moraxella catarrhalis is an important human mucosal pathogen. This study investigated the effect of intranasal immunization with a detoxified-lipooligosaccharide-cross-reactive mutant of diphtheria toxin (dLOS-CRM) vaccine candidate on pulmonary clearance following an aerosol challenge of mice with M. catarrhalis. Intranasal immunization with dLOS-CRM plus cholera toxin induced a significantly dose-dependent increase of immunoglobulin A (IgA) and IgG in the nasal wash, lung lavage fluid, saliva, and fecal extract. In addition, serum IgG, IgM, and IgA against LOS of M. catarrhalis were detected. LOS-specific antibody-forming cells were found in the nasal passages, spleens, nasally associated lymphoid tissues, cervical lymph nodes, lungs, and Peyer's patches using an enzyme-linked immunospot assay. The dLOS-CRM vaccine induced a significant bacterial clearance (70 to 90%) of both homologous and heterologous strains in the lungs compared to that observed in the controls (P < 0.01). Intriguingly, intranasal immunization with dLOS-CRM showed a higher level of bacterial clearance compared with subcutaneous injections with dLOS-CRM. These data indicate that dLOS-CRM induces specific mucosal and systemic immunity through intranasal immunization and also provides effective bacterial clearance. On the basis of these results, we believe that dLOS-CRM should undergo continued testing to determine whether it would induce protective immune response in humans.
* Corresponding author. Mailing address: 5 Research Court, Rockville, MD 20850. Phone: (301) 402-2581. Fax: (301) 402-5354. E-mail: guxx{at}nidcd.nih.gov.
Editor: J. D. Clements
Infection and Immunity, November 2002, p. 5982-5989, Vol. 70, No. 11
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.11.5982-5989.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yu, S., Xie, H., Datta, A., Naidu, N., Gu, X.-X.
(2008). Galactose Residues on the Lipooligosaccharide of Moraxella catarrhalis 26404 Form the Epitope Recognized by the Bactericidal Antiserum from Conjugate Vaccination. Infect. Immun.
76: 4251-4258
[Abstract]
[Full Text]
-
Schwingel, J. M, Michael, F. S., Cox, A. D, Masoud, H., Richards, J. C, Campagnari, A. A
(2008). A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology
18: 447-455
[Abstract]
[Full Text]
-
Yu, S., Gu, X.-X.
(2007). Biological and Immunological Characteristics of Lipooligosaccharide-Based Conjugate Vaccines for Serotype C Moraxella catarrhalis. Infect. Immun.
75: 2974-2980
[Abstract]
[Full Text]
-
Twigg, H. L. III
(2005). Humoral Immune Defense (Antibodies): Recent Advances. Proc Am Thorac Soc
2: 417-421
[Abstract]
[Full Text]
-
Yu, S., Gu, X.-X.
(2005). Synthesis and Characterization of Lipooligosaccharide-Based Conjugate Vaccines for Serotype B Moraxella catarrhalis. Infect. Immun.
73: 2790-2796
[Abstract]
[Full Text]
-
Edwards, K. J., Allen, S., Gibson, B. W., Campagnari, A. A.
(2005). Characterization of a Cluster of Three Glycosyltransferase Enzymes Essential for Moraxella catarrhalis Lipooligosaccharide Assembly. J. Bacteriol.
187: 2939-2947
[Abstract]
[Full Text]
-
Furano, K., Luke, N. R., Howlett, A. J., Campagnari, A. A.
(2005). Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA. Microbiology
151: 1151-1158
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.